Autoimmune encephalitis, neural autoantibody positive (Q100547): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Encefalite autoimune, uma doença inflamatória imunomediada do sistema nervoso central, soropositiva para autoanticorpos neurais. A apresentação é subaguda com dificuldades cognitivas flutuantes (particularmente memória de curto prazo)._x000D_ _x000D_ Os autoanticorpos neurais associados incluem:_x000D_ _x000D_ DPPX (proteína semelhante a dipeptidil peptidase-6); GABAAR (anticorpos de ácido gama-aminobutírico tipo A); gAChR (autoanticorpos ganglionares do receptor de acetilcolina (subunidade alfa-3); GAD65 (anticorpos descarboxilase-65 do ácido glutâmico); VGKC (LGI1, CASPR2) (canal de cálcio controlado por voltagem); | |||||||||||||||
| description / en | description / en | ||||||||||||||
Autoimmune encephalitis, an immune mediated inflammatory disorder of the central nervous system, seropositive for neural autoantibodies. Presentation is subacute with fluctuating cognitive difficulties (particularly short-term memory). Associated neural autoantibodies include: DPPX (dipeptidyl-peptidase–like protein-6); GABAAR (Gamma-aminobutyric-acid type A antibodies); gAChR (ganglionic acetylcholine receptor autoantibodies (alpha-3 subunit); GAD65 (glutamic acid decarboxylase-65 antibodies); VGKC (LGI1, CASPR2) (voltage gated calcium channel); | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/972195461 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_972195461 | |||||||||||||||
| Property / CURIE: CID11:ID_972195461 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_972195461 | |||||||||||||||
| Property / Canary Token: dki-india-ID_972195461 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 17:15, 16 August 2026
Autoimmune encephalitis, an immune mediated inflammatory disorder of the central nervous system, seropositive for neural autoantibodies. Presentation is subacute with fluctuating cognitive difficulties (particularly short-term memory). Associated neural autoantibodies include: DPPX (dipeptidyl-peptidase–like protein-6); GABAAR (Gamma-aminobutyric-acid type A antibodies); gAChR (ganglionic acetylcholine receptor autoantibodies (alpha-3 subunit); GAD65 (glutamic acid decarboxylase-65 antibodies); VGKC (LGI1, CASPR2) (voltage gated calcium channel);
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_972195461 |
||
| English | Autoimmune encephalitis, neural autoantibody positive |
Autoimmune encephalitis, an immune mediated inflammatory disorder of the central nervous system, seropositive for neural autoantibodies. Presentation is subacute with fluctuating cognitive difficulties (particularly short-term memory). Associated neural autoantibodies include: DPPX (dipeptidyl-peptidase–like protein-6); GABAAR (Gamma-aminobutyric-acid type A antibodies); gAChR (ganglionic acetylcholine receptor autoantibodies (alpha-3 subunit); GAD65 (glutamic acid decarboxylase-65 antibodies); VGKC (LGI1, CASPR2) (voltage gated calcium channel); |
Statements
CID11:ID_972195461
0 references
dki-india-ID_972195461
0 references
Concluído
0 references
15 August 2026
0 references
